-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45

Benzinga·10/30/2026 13:59:10
Diffusion vocale
Barclays analyst Christopher Pasquale maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.